Hyundai Pharmaceutical Co., Ltd. (KRX:004310)
South Korea · Delayed Price · Currency is KRW 6,000.00
-110.00 (-1.80%)
Dec 19, 2025, 3:30 PM KST
Hyundai Pharmaceutical Market Cap
Hyundai Pharmaceutical has a market cap or net worth of 166.07 billion as of December 19, 2025. Its market cap has increased by 66.67% in one year.
Market Cap
166.07B
Enterprise Value
n/a
Revenue
108.14B
Ranking
n/a
PE Ratio
99.44
Stock Price
6,000.00
Market Cap Chart
Since August 30, 1995, Hyundai Pharmaceutical's market cap has increased from 28.77B to 166.07B, an increase of 477.12%. That is a compound annual growth rate of 5.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 166.07B | 67.36% |
| Dec 30, 2024 | 99.22B | -12.77% |
| Dec 28, 2023 | 113.76B | -14.20% |
| Dec 29, 2022 | 132.58B | -19.22% |
| Dec 30, 2021 | 164.12B | -22.93% |
| Dec 30, 2020 | 212.94B | 47.61% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 80.45T |
| Celltrion | 39.84T |
| ALTEOGEN | 23.05T |
| ABL Bio | 10.29T |
| SK Biopharmaceuticals | 10.10T |
| Yuhan | 8.52T |
| LigaChem Biosciences | 6.08T |
| HLB Co., Ltd. | 6.05T |